v3.24.3
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2024
Sep. 30, 2023
Cash flows from operating activities:    
Net income including noncontrolling interests $ 71,534 $ 241,288
Adjustments to reconcile net income to net cash from operating activities:    
Depreciation and amortization 75,416 79,629
Non-cash impairment and other charges 96,819 24,882
Share-based compensation expenses related to equity classified awards 20,308 19,671
Non-cash restructuring and other related charges 1,641 11,916
Amortization and write-off of program rights 641,706 626,685
Amortization of deferred carriage fees 18,362 15,662
Unrealized foreign currency transaction (gain) loss (5,311) 7,778
Amortization of deferred financing costs and discounts on indebtedness 5,375 5,876
Deferred income taxes (9,857) 2,973
Other, net (562) (2,775)
Changes in assets and liabilities:    
Accounts receivable, trade (including amounts due from related parties, net) 18,012 48,570
Prepaid expenses and other assets 184,066 141,596
Program rights and obligations, net (691,545) (844,332)
Deferred revenue 2,847 (65,548)
Accounts payable, accrued liabilities and other liabilities (111,304) (182,732)
Net cash provided by operating activities 317,507 131,139
Cash flows from investing activities:    
Capital expenditures (24,252) (28,392)
Return of capital from investees 1,379 696
Proceeds from sale of investments 0 8,565
Other investing activities, net 2,706 (103)
Net cash used in investing activities (20,167) (19,234)
Cash flows from financing activities:    
Proceeds from the issuance of 10.25% Senior Secured Notes due 2029, net 862,969 0
Proceeds from the issuance of 4.25% Convertible Senior Notes due 2029, net 139,437 0
Principal payments on Term Loan A Facility (233,750) (25,313)
Payments for financing costs (10,450) (342)
Deemed repurchases of restricted stock units (4,626) (7,229)
Principal payments on finance lease obligations (3,461) (3,134)
Distributions to noncontrolling interests (18,000) (47,546)
Purchase of noncontrolling interests 0 (1,343)
Net cash used in financing activities (52,739) (84,907)
Net increase in cash and cash equivalents from operations 244,601 26,998
Effect of exchange rate changes on cash and cash equivalents 1,200 (1,813)
Cash and cash equivalents at beginning of period 570,576 930,002
Cash and cash equivalents at end of period 816,377 955,187
4.75% Senior Notes due 2025 | Senior Notes    
Cash flows from financing activities:    
Repayments of senior debt (774,729) 0
4.25% Senior Notes due 2029 | Senior Notes    
Cash flows from financing activities:    
Repayments of senior debt $ (10,129) $ 0